CAS
Coppell Advisory Solutions’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.23M | Sell |
20,144
-3,179
| -14% | -$352K | 0.26% | 73 |
|
|
2025
Q1 | $2.43M | Sell |
23,323
-11,719
| -33% | -$1.22M | 0.34% | 62 |
|
|
2024
Q4 | $3.22M | Sell |
35,042
-2,556
| -7% | -$235K | 0.45% | 40 |
|
|
2024
Q3 | $3.14M | Sell |
37,598
-373
| -1% | -$31.2K | 0.46% | 38 |
|
|
2024
Q2 | $2.61M | Buy |
+37,971
| New | +$2.61M | 0.43% | 48 |
|
|
2023
Q4 | $2.2M | Buy |
27,142
+9,049
| +50% | +$733K | 0.44% | 50 |
|
|
2023
Q3 | $1.55M | Sell |
18,093
-4,218
| -19% | -$362K | 0.53% | 48 |
|
|
2023
Q2 | $1.7M | Buy |
22,311
+3,177
| +17% | +$241K | 0.48% | 46 |
|
|
2023
Q1 | $1.56M | Buy |
19,134
+1,041
| +6% | +$84.8K | 0.51% | 46 |
|
|
2022
Q4 | $1.55M | Buy |
+18,093
| New | +$1.55M | 0.53% | 48 |
|
|
2020
Q4 | $548K | Buy |
+9,402
| New | +$548K | 0.28% | 95 |
|